Tricare Pharmacy Program RFI (draft Section C & H)

Defense Health Agency · United States government procurement

Closed May 11, 2026. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

The Defense Health Agency (DHA) is in the acquisition planning phase for the next generation TRICARE Pharmacy Program (TPharm6) contract. These draft documents are provided for industry’s feedback and refinement. The Government invites qualified vendors to submit feedback and questions on the following draft documents:

Section C, Statement of Work
Section H, Special Contract Requirements

The DHA will facilitate one-on-one meetings with industry to gather additional feedback and answer questions related to the draft documents in the summer of 2026. Please follow the instructions below to request a one-on-one meeting and to submit questions, comments, or general feedback.

Instructions

Comments and questions specific to Section C and Section H must be submitted no later than May 11, 2026 at 12:00PM Mountain Time to dha.buckley.AD-SPT-CAE.mbx.tpharm6@health.mil. Include in the email subject line the following: Your Company Name and Draft Documents Response.

One-On-One Meetings: Requests for a one-on-one meeting with the DHA related to TPharm6 can be made using the link - https://forms.osi.apps.mil/r/zBn9EyRm0g. The request for one-on-one meeting attendance must be submitted no later than May 11, 2026 at 12:00PM Mountain Time.

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyDefense Health Agency
CountryUnited States
CategoryMedical Equipment
NAICS524114
PSCQ201
PublishedApril 16, 2026
Procurement stageActive solicitation
ClosedMay 11, 2026
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: U.S. Government (SAM.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

Browse Similar Open Opportunities in United States

Transformative Non-Invasive/Minimally Invasive Technologies for Imaging the Olfactory System Across Scales (R01 CT Optional)
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)
Acute Hemodialysis Treatments and Equipment Maintenance
Q402--Q402- Atlanta VAMC Community Nursing Home Services
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
Non-Personal Healthcare Services-Physicians & Other Professional Ambulatory Services for PRC Program

See every United States Medical Equipment opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United States Medical Equipment intelligence report in your inbox

A personalized report on United States Medical Equipment opportunities, emailed in 5-10 minutes. One per month, no account needed.